Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT studyReinhard Dummer, Michael R. Migden, Karl D. Lewis et al.|British Journal of Dermatology|2019Cited by 197
Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysisJohn T. Lear, Reinhard Dummer, A Guminski et al.|Melanoma Research|2016Cited by 1